Impact of Genetic Polymorphisms on the Efficacy of HMG-CoA Reductase Inhibitors

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.8, Iss.3, 2008-01, pp. : 161-170

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Genetic Polymorphisms in Cytochrome P450 Enzymes: Effect on Efficacy and Tolerability of HMG-CoA Reductase Inhibitors

By Andras Vermes

American Journal of Cardiovascular Drugs, Vol. 4, Iss. 4, 2004-01 ,pp. : 247-255

Adis International

Access to resources Recommend Favorite

The Effects of HMG-CoA Reductase Inhibitors on Endothelial Function

By Tesfamariam Belay

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 2, 2006-01 ,pp. : 115-120

Adis International

Access to resources Recommend Favorite

HMG-CoA Reductase Inhibitors in the Prevention of Stroke

By van Mil A.H.M.

Drugs, Vol. 59, Iss. 1, 2000-01 ,pp. : 1-6

Adis International

Access to resources Recommend Favorite

Comparative Tolerability of the HMG-CoA Reductase Inhibitors

By Farmer J.A. Torre-Amione G.

Drug Safety, Vol. 23, Iss. 3, 2000-09 ,pp. : 197-213

Adis International

Access to resources Recommend Favorite

Inhibitors of HMG-CoA Reductase: Current and Future Prospects

Mini Reviews in Medicinal Chemistry, Vol. 9, Iss. 11, 2009-01 ,pp. : 1272-1283

Bentham Science Publishers

Access to resources Recommend Favorite